Fig. 2.

Histological sections immunostained with anti Ki67 antibody. Negative control, SMM (a and e); positive controls, PBS1X and LPS 100 μg/Ml (b and f, respectively); anti-inflammatory reference treatments, PBS 1X and LPS 100 μg/mL + Dexamethasone 10 μM (c and g, respectively); HT-based formulation treatments, PBS 1 X and LPS 100 μg/mL + Fenolia® Eudermal Cream 15 (d and h, respectively) for 24 h. Scale bar: 50 μm